Member of the Association of American Physicians
Internal medicine, Cardiology, Heart failure, Endocrinology and Heart disease are his primary areas of study. As a part of the same scientific study, Joshua M. Hare usually deals with the Internal medicine, concentrating on Surgery and frequently concerns with Incidence. His Cardiology study integrates concerns from other disciplines, such as Randomized controlled trial and Hazard ratio.
His Heart failure research integrates issues from Anesthesia and Pulmonary artery. His work is dedicated to discovering how Endocrinology, Xanthine oxidase are connected with Reactive oxygen species and Circulatory system and other disciplines. His Heart disease research includes themes of Pathophysiology and Heart rate.
His primary areas of investigation include Internal medicine, Cardiology, Stem cell, Heart failure and Mesenchymal stem cell. In his research on the topic of Internal medicine, Receptor is strongly related with Endocrinology. The Cardiology study combines topics in areas such as Surgery, Transplantation and Diastole.
His studies in Heart failure integrate themes in fields like Xanthine oxidase and Heart disease. He interconnects Cancer research, Clinical trial and Bone marrow in the investigation of issues within Mesenchymal stem cell. His Nitric oxide research includes elements of Reactive oxygen species and Biochemistry.
His main research concerns Internal medicine, Stem cell, Mesenchymal stem cell, Cardiology and Heart failure. His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology and Cell therapy. The concepts of his Stem cell study are interwoven with issues in Transplantation, Hedgehog signalling, Kidney and Function.
His research in Mesenchymal stem cell focuses on subjects like Cancer research, which are connected to Prostate cancer, Nitric oxide and Carcinogenesis. His study explores the link between Cardiology and topics such as Stem-cell therapy that cross with problems in Stroke, Cell and Heart disease. Joshua M. Hare usually deals with Heart failure and limits it to topics linked to Clinical trial and Surgery and Placebo.
Joshua M. Hare spends much of his time researching Internal medicine, Mesenchymal stem cell, Stem cell, Heart failure and Cardiology. His Internal medicine course of study focuses on Endocrinology and Endothelial stem cell. Joshua M. Hare has included themes like Progenitor cell, Stromal cell, Regenerative medicine and Paracrine signalling in his Mesenchymal stem cell study.
The various areas that Joshua M. Hare examines in his Stem cell study include Clinical trial, Podocyte, Transplantation and Homeostasis. His research investigates the connection between Heart failure and topics such as Intensive care medicine that intersect with issues in Position paper and MEDLINE. In Cardiology, Joshua M. Hare works on issues like Stem-cell therapy, which are connected to Cell and Ischemia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
FGF23 induces left ventricular hypertrophy
Christian Faul;Ansel P. Amaral;Behzad Oskouei;Ming Chang Hu.
Journal of Clinical Investigation (2011)
Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.
G M Felker;R E Thompson;J M Hare;R H Hruban.
The New England Journal of Medicine (2000)
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness
James A. Hill;Daniel F. Pauly;Debra R. Olitsky;Stuart Russell.
A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction
Joshua M. Hare;Jay H. Traverse;Timothy D. Henry;Nabil Dib.
Journal of the American College of Cardiology (2009)
Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial
Joshua M. Hare;Joel E. Fishman;Gary Gerstenblith;Darcy L. DiFede Velazquez.
Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction
Luciano C. Amado;Anastasios P. Saliaris;Karl H. Schuleri;Marcus St. John.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Regenerative Potential of Cardiosphere-Derived Cells Expanded From Percutaneous Endomyocardial Biopsy Specimens
Rachel Ruckdeschel Smith;Lucio Barile;Lucio Barile;Hee Cheol Cho;Michelle K. Leppo.
Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications
Cristine E. Berry;Joshua M. Hare.
The Journal of Physiology (2004)
Mesenchymal Stem Cells Biology, Pathophysiology, Translational Findings, and Therapeutic Implications for Cardiac Disease
Ashley R. Williams;Joshua M. Hare.
Circulation Research (2011)
Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis.
Robert E. McCarthy;John P. Boehmer;Ralph H. Hruban;Grover M. Hutchins.
The New England Journal of Medicine (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: